{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:51:46Z","timestamp":1793911906302,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"publisher","award":["R24 AT001293"],"award-info":[{"award-number":["R24 AT001293"]}],"id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Elderberry has traditionally been used to prevent and treat respiratory problems. During the COVID-19 pandemic, there has been interest in elderberry supplements to treat or prevent illness, but also concern that elderberry might overstimulate the immune system and increase the risk of \u2018cytokine storm\u2019. We aimed to determine benefits and harms of elderberry for the prevention and treatment of viral respiratory infections, and to assess the relationship between elderberry supplements and negative health impacts associated with overproduction of pro-inflammatory cytokines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and searched six databases, four research registers, and two preprint sites for studies. Two reviewers independently assessed studies for inclusion, extracted data from studies, assessed risk of bias using Cochrane tools, and evaluated certainty of estimates using GRADE. Outcomes included new illnesses and the severity and duration of illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We screened 1187 records and included five randomized trials on elderberry for the treatment or prevention of viral respiratory illness. We did not find any studies linking elderberry to clinical inflammatory outcomes. However, we found three studies measuring production of cytokines ex vivo after ingestion of elderberry. Elderberry may not reduce the risk of developing the common cold; it may reduce the duration and severity of colds, but the evidence is uncertain. Elderberry may reduce the duration of influenza but the evidence is uncertain. Compared to oseltamivir, an elderberry-containing product may be associated with a lower risk of influenza complications and adverse events. We did not find evidence on elderberry and clinical outcomes related to inflammation. However, we found evidence that elderberry has some effect on inflammatory markers, although this effect may decline with ongoing supplementation. One small study compared elderberry to diclofenac (a nonsteroidal anti-inflammatory drug) and provided some evidence that elderberry is as effective or less effective than diclofenac in cytokine reduction over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elderberry may be a safe option for treating viral respiratory illness, and there is no evidence that it overstimulates the immune system. However, the evidence on both benefits and harms is uncertain and information from recent and ongoing studies is necessary to make firm conclusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-021-03283-5","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T15:03:07Z","timestamp":1617807787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2157-0603","authenticated-orcid":false,"given":"L. Susan","family":"Wieland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Piechotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Termeh","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Ludeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dugald","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantelle","family":"Garritty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"3283_CR1","unstructured":"In the News: Coronavirus and \u201cAlternative\u201d Treatments. https:\/\/www.nccih.nih.gov\/health\/in-the-news-coronavirus-and-alternative-treatments. [Accessed August 31, 2020]."},{"issue":"1","key":"3283_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/19390211.2013.859852","volume":"11","author":"C Ulbricht","year":"2014","unstructured":"Ulbricht C, Basch E, Cheung L, Goldberg H, Hammerness P, Isaac R, et al. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the natural standard research collaboration. J Diet Suppl. 2014;11(1):80\u2013120. https:\/\/doi.org\/10.3109\/19390211.2013.859852.","journal-title":"J Diet Suppl"},{"key":"3283_CR3","volume-title":"Native American medicinal plants : an ethnobotanical dictionary","author":"DE Moerman","year":"2009","unstructured":"Moerman DE, Moerman DE. Native American medicinal plants : an ethnobotanical dictionary. Portland, Or.: Timber Press; 2009."},{"key":"3283_CR4","doi-asserted-by":"publisher","unstructured":"Knudsen BF, Kaack KV. A review of human health and disease claims for elderberry (Sambucus Nigra) Fruit. Acta Hortic. 2015;1061:121\u201331. https:\/\/doi.org\/10.17660\/ActaHortic.2015.1061.12.","DOI":"10.17660\/ActaHortic.2015.1061.12"},{"key":"3283_CR5","doi-asserted-by":"publisher","unstructured":"Knudsen BF, Kaack KV. A review of traditional herbal medicinal products with disease claims for elder (Sambucus Nigra) flower. Acta Hortic. 2015;1061:109\u201320. https:\/\/doi.org\/10.17660\/ActaHortic.2015.1061.11.","DOI":"10.17660\/ActaHortic.2015.1061.11"},{"key":"3283_CR6","unstructured":"European Medicines Agency (EMA). Elder flower https:\/\/www.ema.europa.eu\/en\/documents\/herbal-summary\/elder-flower-summary-public_en.pdf. 2018. Accessed 25 May 2020."},{"key":"3283_CR7","unstructured":"Smith T, Gillespie M, Eckl V, Knepper J, Reynolds CM. Herbal Supplement Sales in US Increase by 9.4% in 2018 http:\/\/cms.herbalgram.org\/herbalgram\/issue123\/files\/HG123-HMR.pdf. American Herbal Council Market Report 2019 (123):62\u201373 [Accessed 25 May 2020]."},{"key":"3283_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ctim.2018.12.004","volume":"42","author":"J Hawkins","year":"2019","unstructured":"Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials. Complement Ther Med. 2019;42:361\u20135. https:\/\/doi.org\/10.1016\/j.ctim.2018.12.004.","journal-title":"Complement Ther Med"},{"key":"3283_CR9","unstructured":"U.S. Food and Drug Administration (FDA). https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/center-new-medicineperfectly-healthy-connealy-md-605804-05112020. 2020 [Accessed 21 May 2020]."},{"issue":"2","key":"3283_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/147323000403200205","volume":"32","author":"Z Zakay-Rones","year":"2004","unstructured":"Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza a and B virus infections. J Int Med Res. 2004;32(2):132\u201340. https:\/\/doi.org\/10.1177\/147323000403200205.","journal-title":"J Int Med Res"},{"issue":"1","key":"3283_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6882-11-16","volume":"11","author":"C Krawitz","year":"2011","unstructured":"Krawitz C, Mraheil MA, Stein M, Imirzalioglu C, Domann E, Pleschka S, et al. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza a and B viruses. BMC Complement Altern Med. 2011;11(1):16. https:\/\/doi.org\/10.1186\/1472-6882-11-16.","journal-title":"BMC Complement Altern Med"},{"key":"3283_CR12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jff.2019.01.031","volume":"54","author":"G Torabian","year":"2019","unstructured":"Torabian G, Valtchev P, Adil Q, Dehghani F. Anti-influenza activity of elderberry (Sambucus nigra). J Funct Foods. 2019;54:353\u201360. https:\/\/doi.org\/10.1016\/j.jff.2019.01.031.","journal-title":"J Funct Foods"},{"issue":"10","key":"3283_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.phytochem.2009.06.003","volume":"70","author":"B Roschek Jr","year":"2009","unstructured":"Roschek B Jr, Fink RC, McMichael MD, Li D, Alberte RS. Elderberry flavonoids bind to and prevent H1N1 infection in vitro. Phytochemistry. 2009;70(10):1255\u201361. https:\/\/doi.org\/10.1016\/j.phytochem.2009.06.003.","journal-title":"Phytochemistry."},{"issue":"2","key":"3283_CR14","first-page":"290","volume":"12","author":"V Barak","year":"2001","unstructured":"Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw. 2001;12(2):290\u20136.","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"3283_CR15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.phymed.2015.12.002","volume":"23","author":"TV Kirichenko","year":"2016","unstructured":"Kirichenko TV, Sobenin IA, Nikolic D, Rizzo M, Orekhov AN. Anti-cytokine therapy for prevention of atherosclerosis. Phytomedicine. 2016;23(11):1198\u2013210. https:\/\/doi.org\/10.1016\/j.phymed.2015.12.002.","journal-title":"Phytomedicine."},{"issue":"6","key":"3283_CR16","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","volume":"8","author":"RJ Jose","year":"2020","unstructured":"Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46\u20137. https:\/\/doi.org\/10.1016\/S2213-2600(20)30216-2.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3283_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16\u201332. https:\/\/doi.org\/10.1128\/MMBR.05015-11.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3283_CR18","unstructured":"Andrew Weill Center for Integrative Medicine, University of Arizona. COVID-19 FAQ. https:\/\/integrativemedicine.arizona.edu\/COVID19\/FAQ.html. 2020 [Accessed 21 May 2020]."},{"key":"3283_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.021.","journal-title":"J Clin Epidemiol"},{"key":"3283_CR20","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org. Accessed 20 Aug 2020."},{"key":"3283_CR21","unstructured":"Higgins J, Altman D, Sterne Je. Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions version 5.20 (updated June 2017) [Internet]. Cochrane. 2017. Available from www.training.cochrane.org\/handbook. Accessed 20 Aug 2020,"},{"key":"3283_CR22","unstructured":"Cochrane Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. 2017. epoc.cochrane.org\/resources\/epoc-resources-review-authors. Accessed 10 Aug 2020."},{"key":"3283_CR23","volume-title":"Version 5.4, The Cochrane Collaboration","author":"Review Manager (RevMan) [Computer program]","year":"2020","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.4, The Cochrane Collaboration, 2020."},{"key":"3283_CR24","unstructured":"Deeks J, Higgins J, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions version 60 (updated July 2019) [Internet]. Cochrane, 2019. Available from www.training.cochrane.org\/handbook. Accessed 20 Aug 2020."},{"key":"3283_CR25","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann H, Higgins J, Vist G, Glasziou P, Akl E, Skoetz N, et al. Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. . In: Cochrane Handbook for Systematic Reviews of Interventions version 60 (updated July 2019) [Internet]. Cochrane, 2019. Available from www.training.cochrane.org\/handbook. Accessed 20 Aug 2020.","DOI":"10.1002\/9781119536604.ch14"},{"issue":"7","key":"3283_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"3283_CR27","unstructured":"ACTRN12615000506594. A double-blind, randomised, placebo-controlled study to evaluate the safety and efficacy of Sambucol liquid formulation to reduce the duration and severity of the common cold and flu symptoms in adults [A prospective, double-blind, randomised, placebo-controlled study to evaluate the safety and efficacy of a complementary medicine formulation, to help reduce duration and severity of cold and flu symptoms, in otherwise health adults]. (submitted on 6\/05\/2015). https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReviewaspx?id=368487. Accessed 20 Aug 2020."},{"key":"3283_CR28","doi-asserted-by":"publisher","unstructured":"ISRCTN84244658. The use of Sambucus Comp. in the treatment of postnasal drip. https:\/\/doi.org\/10.1186\/ISRCTN84244658. (first submitted 30 September 2004).","DOI":"10.1186\/ISRCTN84244658"},{"key":"3283_CR29","unstructured":"NCT02003651. Echinacea and acute respiratory illness [Efficacy of ingesting gaia herb's quick defense product in reducing acute respiratory illness symptomatology in women: a 12-week, double blind, placebo-controlled randomized trial]. (posted on December 6, 2013). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02003651. Accessed 20 Aug 2020."},{"key":"3283_CR30","unstructured":"NCT02414607. Effect of elderberry juice on cognition and inflammation in patients with mild cognitive impairment. (first submitted March 20, 2015). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02414607. Accessed 20 Aug 2020."},{"key":"3283_CR31","unstructured":"NCT03410862. Evaluating the safety and clinical efficacy of elderberry extract in patients with influenza https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03410862 [Phase IV study evaluating the safety and clinical efficacy of elderberry extract in patients with influenza: a randomized, double-blind placebo-controlled trial]. (submitted on January 19, 2018). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03410862. Accessed 20 Aug 2020."},{"key":"3283_CR32","unstructured":"CTRI\/2019\/11\/021852. Treatment of upper respiratory infection [A randomized, open label, pilot, interventional study to evaluate the efficacy and safety of beta-glucan, elderberry, acerola extracts, ascorbic acid and zinc combination in patients with upper respiratory tract infection]."},{"issue":"4","key":"3283_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/nu8040182","volume":"8","author":"E Tiralongo","year":"2016","unstructured":"Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, Double-Blind Placebo-Controlled Clinical Trial. Nutrients. 2016;8(4):182. https:\/\/doi.org\/10.3390\/nu8040182.","journal-title":"Nutrients"},{"issue":"4","key":"3283_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/acm.1995.1.361","volume":"1","author":"Z Zakay-Rones","year":"1995","unstructured":"Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995;1(4):361\u20139. https:\/\/doi.org\/10.1089\/acm.1995.1.361.","journal-title":"J Altern Complement Med"},{"key":"3283_CR35","first-page":"32","volume":"5","author":"F Kong","year":"2009","unstructured":"Kong F. Pilot clinical study on a proprietary elderberry extract: efficacy in addressing influenza symptoms. Online J Pharmacol PharmacoKinetics. 2009;5:32\u201343.","journal-title":"Online J Pharmacol PharmacoKinetics"},{"key":"3283_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.curtheres.2015.04.001","volume":"77","author":"K Rau\u0161","year":"2015","unstructured":"Rau\u0161 K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an Echinacea-based hot drink versus Oseltamivir in influenza treatment: a randomized, double-blind, double-dummy, multicenter, noninferiority clinical trial. Curr Ther Res Clin Exp. 2015;77:66\u201372. https:\/\/doi.org\/10.1016\/j.curtheres.2015.04.001.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"12","key":"3283_CR37","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3945\/jn.109.113126","volume":"139","author":"PJ Curtis","year":"2009","unstructured":"Curtis PJ, Kroon PA, Hollands WJ, Walls R, Jenkins G, Kay CD, et al. Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr. 2009;139(12):2266\u201371. https:\/\/doi.org\/10.3945\/jn.109.113126.","journal-title":"J Nutr"},{"key":"3283_CR38","volume-title":"The impact of human intervention studies on the evaluation of medicinal plant antioxidant and anti-inflammatory activities. Chapter VII. Human Health and Nutrition: New Research; edited by Sergej M. Ostojic (Nova Science Publishers, Incorporated","author":"D Ivanova","year":"2015","unstructured":"Ivanova D, Nahar M, Kiselova-Kaneva Y, Tasinov O, Vankova D, Nazifova-Tasinova N. The impact of human intervention studies on the evaluation of medicinal plant antioxidant and anti-inflammatory activities. Chapter VII. Human Health and Nutrition: New Research; edited by Sergej M. Ostojic (Nova Science Publishers, Incorporated, 2015). ISBN 1634828232, 9781634828239."},{"issue":"3","key":"3283_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10517-007-0099-6","volume":"143","author":"TV Gorchakova","year":"2007","unstructured":"Gorchakova TV, Suprun IV, Sobenin IA, Orekhov AN. Use of natural products in anticytokine therapy. Bull Exp Biol Med. 2007;143(3):316\u20139. https:\/\/doi.org\/10.1007\/s10517-007-0099-6.","journal-title":"Bull Exp Biol Med"},{"key":"3283_CR40","unstructured":"NCT03410862. Evaluating the safety and clinical efficacy of elderberry extract in patients with influenza (Phase IV study evaluating the safety and clinical efficacy of elderberry extract in patients with influenza: a randomized, double-blind placebo-controlled trial). (submitted on January 19, 2018). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03410862. Accessed 20 Aug 2020."},{"key":"3283_CR41","unstructured":"CTRI\/2019\/11\/021852. Treatment of Upper Respiratory Infection (A Randomized, Open label, Pilot, Interventional study To Evaluate the Efficacy and Safety of BETA-GLUCAN, ELDERBERRY, ACEROLA EXTRACTS, ASCORBIC ACID AND ZINC Combination in patients with Upper Respiratory tract Infection). (registered on 04\/11\/2019). http:\/\/ctri.nic.in\/Clinicaltrials\/showallpphp?mid1=37595&EncHid=&userName=elderberry. Accessed 20 Aug 2020."},{"issue":"11 Suppl","key":"3283_CR42","first-page":"919","volume":"4","author":"V Barak","year":"2002","unstructured":"Barak V, Birkenfeld S, Halperin T, Kalickman I. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc J. 2002;4(11 Suppl):919\u201322.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"3283_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13104-015-1181-1","volume":"8","author":"SR O'Connor","year":"2015","unstructured":"O'Connor SR, Tully MA, Ryan B, Bradley JM, Baxter GD, McDonough SM. Failure of a numerical quality assessment scale to identify potential risk of bias in a systematic review: a comparison study. BMC Res Notes. 2015;8(1):224. https:\/\/doi.org\/10.1186\/s13104-015-1181-1.","journal-title":"BMC Res Notes"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-021-03283-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:14:58Z","timestamp":1671801298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-021-03283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1186\/s12906-021-03283-5","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LSW is a Systematic Review Editor with BMC Complementary Medicine and Therapies and Coordinator of the Cochrane Complementary Medicine Field. The authors declare that they have no further competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}